EVENITY (romosozumab) injection, submitted by Amgen, for the treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant of other available osteoporosis therapy
Read MoreJAN 10 BRUDAC
Oral testosterone undecanoate capsules by Lipocine Inc.
Read MoreJAN 9 BRUDAC
Oral testosterone undecanoate capsules, submitted by Clarus Therapeutics, Inc.
Read MoreJAN 9 BRUDAC
Oral testosterone undecanoate capsules by Clarus Therapeutics, Inc
Read MoreDEC 7 BRUDAC
Trial designs for drugs to treat interstitial cystitis and bladder pain syndrome
Read MoreDEC 7 BRUDAC
Trial designs for drugs to treat interstitial cystitis and bladder pain syndrome
Read MoreJAN 9 BRUDAC
Oral testosterone undecanoate capsules, submitted by Clarus Therapeutics, Inc.
Read MoreJAN 10 BRUDAC
Oral testosterone undecanoate capsules by Lipocine Inc.
Read MoreDEC 7 BRUDAC
Trial designs for drugs to treat interstitial cystitis and bladder pain syndrome
Read MoreDEC 7 BRUDAC
Trial designs for drugs to treat interstitial cystitis and bladder pain syndrome
Read MoreDEC 6 BRUDAC
Clinical trial design features, including acceptable endpoints for demonstrating clinical benefit, for drugs intended to treat secondary hypogonadism while preserving or improving testicular function, including spermatogenesis
Read MoreDEC 6 BRUDAC
Clinical trial design features, including acceptable endpoints for demonstrating clinical benefit, for drugs intended to treat secondary hypogonadism while preserving or improving testicular function, including spermatogenesis
Read MoreOCT 19 BRUDAC
Serenity Pharmaceuticals' desmopressin nasal spray for the treatment of adult onset nocturia
Read MoreOCT 19 BRUDAC
Serenity Pharmaceuticals' desmopressin nasal spray for the treatment of adult onset nocturia
Read MoreDEC 6 BRUDAC
Clinical trial design features, including acceptable endpoints for demonstrating clinical benefit, for drugs intended to treat secondary hypogonadism while preserving or improving testicular function, including spermatogenesis
Read MoreDEC 6 BRUDAC
Clinical trial design features, including acceptable endpoints for demonstrating clinical benefit, for drugs intended to treat secondary hypogonadism while preserving or improving testicular function, including spermatogenesis
Read MoreOCT 19 BRUDAC
Serenity Pharmaceuticals' desmopressin nasal spray for the treatment of adult onset nocturia
Read MoreNOV 3 BRUDAC
Repros Therapeutics' Androxal (enclomiphene) for hypogonadism
Read MoreJUN 4 BRUDAC
Sprout Pharmaceuticals' flibanserin for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women
Read MoreJUN 4 BRUDAC
Sprout Pharmaceuticals' flibanserin for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women
Read More